Almac Announces Launch of Next Generation Sequencing Service
News Aug 21, 2012
The purpose of this service is to support Almac’s BioPharma partners in the development of molecular tests for trial enrichment and companion diagnostic development, specifically focussing on targeted re-sequencing.
Almac currently offer solutions using microarray, qPCR and IHC and the addition of the Next Generation Sequencing (NGS) platform fully complements this range of clinically focused diagnostic delivery platforms.
Almac previously launched a service focussing on the analysis of Next Generation Sequencing (NGS) data and based on feedback from the market has decided to develop this service further to include data generation and to allow the delivery of NGS based assays in their CLIA lab.
Professor Paul Harkin, President and Managing Director of Almac’s Diagnostics business unit and Professor of Molecular Oncology at Queens University Belfast said:
“There are only a limited number of platforms that are truly amenable to diagnostic delivery. The NGS field has now moved to a point where it is a viable delivery platform and as such is a logical addition to our suite of services. We have already begun the process of developing CLIA based assays for important mutations involved in drug response.”
Almac already perform Next Generation Sequencing for Omixon, a bioinformatics company focused on the development of validated data analysis solutions to scientists working in genomics with special emphasis on clinical and diagnostic applications. Attila Bérces, founder and Chief Executive Officer of Omixon said:
“Omixon aims to provide the most accurate and highest quality DNA analysis software. Almac complements our effort by providing the highest quality sequencing data. The MiSeq data we received from Almac is of highest quality which helped Omixon in developing and validating our HLA-typing software. Next Generation Sequencing can revolutionize HLA-typing which is carried out on millions of samples annually.”
Kidney Disease Diagnosis May Benefit from DNA SequencingNews
DNA sequencing yielded clinically meaningful insight into the cause, and treatment, of many types of kidney disease.READ MORE
New Software Could Help Improve Cell-AuthenticationNews
Researchers at Columbia University and the New York Genome Center have developed a method to quickly and accurately identify people and cell lines from their DNA.READ MORE
Comparative Transcriptomic Analysis Between Humans and Non-Human Primate Brains Reveals What Makes us HumanNews
A large-scale study performed histological and transcriptomic analysis on human and non-human primate brains to compare differences.READ MORE